JAN 11, 2020 06:13 AM PST

Should we be concerned about talc powder and ovarian cancer?

After the outcry against baby powder and concerns regarding its link to ovarian cancer, still, no investigations have clearly linked the product to the disease. Nevertheless, caution is advised, urge experts.

The most recent study on the topic was published recently in JAMA and conducted with over 250,000 women, making it the most extensive study yet. However, Katie O'Brien from the Chronic Disease Epidemiology Group at the National Institute of Environmental Health Sciences, part of the United States National Institute of Health, and her co-authors say that it still might not be large enough to come to any significant conclusions.

"Previous studies had reported a possible positive association between genital powder use and ovarian cancer, but my co-authors and I saw an opportunity to do a very large study that also addressed some of the potential limitations of the previous ones," stated O’Brien. [Yet] "Despite being the largest study to date, it was not big enough to detect a small change in risk of ovarian cancer, which is a fairly rare cancer."

The study analyzed data on genital powder from four cohort studies: Nurses' Health Study, Nurses' Health Study II, Sister Study, and the Women's Health Initiative Observational Study. Encompassing data from 257,044 women, the research team wanted to see if there was a definitive association between using genital powder and developing ovarian cancer.

Their findings showed that there was not a significant association between the two. "In this pooled analysis of four large U.S. cohorts, there was no statistically significant association between self-reported use of powder in the genital area and risk of ovarian cancer," the authors write in the paper.

Does talc powder show an association with ovarian cancer? Photo: Pixabay

Nevertheless, the authors caution that their study, despite its size, was restricted by certain limitations in terms of data collection and sub-populations. To strengthen their findings, more analyses should be conducted, they urge, while at the same time noting the unlikeliness of this, given the limited information available for investigation.

Sources: JAMA, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 20, 2020
Cancer
JAN 20, 2020
Using temperature to awaken immune response to fight brain cancer
Glioblastoma is the most common form of adult brain cancer and also one of the most aggressive human cancers. Immunotherapy has yet to be shown proven effe...
JAN 20, 2020
Cancer
JAN 20, 2020
Looking at the bigger picture: immune cells in a human body
While laboratory-conducted research has allowed for countless scientific advancements over the years, it may not come as a surprise that studying cells in ...
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Membrane-less Organelle Found to Play a Role in Preventing Cancer
In recent years, scientists have found that a phenomenon called phase separation plays a critical role in the functions of cells....
JAN 20, 2020
Immunology
JAN 20, 2020
Harnessing the Power of Natural Killer Cells to Fight Cancer
Manipulating the immune system’s population of natural killer cells could bolster therapies targeting cancer. A new study saw positive results invest...
JAN 20, 2020
Drug Discovery & Development
JAN 20, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 20, 2020
Immunology
JAN 20, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
Loading Comments...